Emerging Risk Factors for Atherosclerotic Vascular Disease
Top Cited Papers
- 20 August 2003
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA
- Vol. 290 (7), 932-940
- https://doi.org/10.1001/jama.290.7.932
Abstract
Research from JAMA — Emerging Risk Factors for Atherosclerotic Vascular Disease — A Critical Review of the Evidence — ContextAtherosclerotic vascular disease is an enormous public health problem. A number of emerging risk factors for atherosclerosis have recently been proposed to help identify high-risk individuals.ObjectiveTo review the epidemiological, basic science, and clinical trial evidence concerning 4 emerging risk factors: C-reactive protein, lipoprotein(a), fibrinogen, and homocysteine.Data SourcesUsing the terms atherosclerosis, cardiovascular disease, risk factors, prevention, screening, C-reactive protein, lipoprotein(a), fibrinogen, and homocysteine, we searched the MEDLINE database from January 1990 to January 2003. Conference proceedings, abstract booklets, bibliographies of pertinent articles and books, and personal files were hand searched to identify additional articles.Study SelectionOriginal investigations and reviews of the epidemiology of atherosclerosis and the association of conventional and novel risk factors with vascular risk were selected. On the basis of the search strategy, 373 relevant studies were identified.Data ExtractionA diverse array of studies were examined, including randomized controlled trials, prospective cohort studies, systematic overviews, case-control, cross-sectional, and mechanistic studies. Data extraction was performed by one of the authors.Data SynthesisThe available epidemiological and basic science evidence supports, to varying degrees, independent associations between these 4 candidate risk factors and atherosclerotic vascular disease. However, there is relatively little data regarding the additive yield of screening for these factors over that of validated global risk assessment strategies currently in use. Furthermore, controlled intervention studies targeting individuals with these factors for proven risk-reduction therapies, or specifically treating these factors with available therapies, are few. The explanatory power of the major, established cardiovascular risk factors has been systematically underestimated.ConclusionsAlthough C-reactive protein, lipoprotein(a), fibrinogen, and homocysteine are associated with vascular disease risk, their optimal use in routine screening and risk stratification remains to be determined.Keywords
This publication has 78 references indexed in Scilit:
- Homocystinuria, Arteriosclerosis, Methylmalonic Aciduria, and Methyltransferase Deficiency: A Key Case RevisitedNutrition Reviews, 2009
- The search for new risk factors for coronary heart disease: occupational therapy for epidemiologists?International Journal of Epidemiology, 2002
- Lowering plasma homocysteine with folic acid in cardiovascular disease: what will the trials tell us?Atherosclerosis, 2002
- Lipoprotein(a): from ancestral benefit to modern pathogen?QJM: An International Journal of Medicine, 2000
- A meta-analysis of cerebrovascular disease and hyperhomocysteinaemiaScandinavian Journal of Clinical and Laboratory Investigation, 2000
- C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the Intima of Early Atherosclerotic Lesions of Human Coronary ArteriesArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.JCI Insight, 1997
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Measuring plasma fibrinogen to predict stroke and myocardial infarction.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990